Sierra Oncology to Hold Year End 2019 & 2020 Outlook Analyst & Investor Call by Seini Moimoi | Feb 26, 2020 | Portfolio News
Akebia Therapeutics to Report 4th Quarter and Full-Year 2019 Financial Results and Discuss Recent Business Highlights by Seini Moimoi | Feb 24, 2020 | Portfolio News
Aimmune Therapeutics Announces Additional $200 Million Equity Investment by Nestlé Health Science by Seini Moimoi | Feb 5, 2020 | Portfolio News
Aimmune Licenses Exclusive Worldwide Rights to Xencor’s XmAb®7195 for the Development of Next-Generation Food Allergy Treatments by Seini Moimoi | Feb 5, 2020 | Portfolio News
FDA Approves Aimmune’s PALFORZIA™ as First Treatment for Peanut Allergy by Seini Moimoi | Jan 31, 2020 | Portfolio News
